Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables

Archives of Surgery

Volumn 144, Issue 1, 2009, Pages 57-63

  Cescon, Matteo ^a,c   Cucchetti, Alessandro ^a   Grazi, Gian Luca ^a   Ferrero, Alessandro ^b   Viganò, Luca ^b   Ercolani, Giorgio ^a   Zanello, Matteo ^a   Ravaioli, Matteo ^a   Capussotti, Lorenzo ^b   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM;

ADULT; AGED; ARTICLE; BILIARY TRACT SURGERY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SODIUM BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 58749114739     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2008.522     Document Type: Article

References (31)

1. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321-328.
2. Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004;10(2)(suppl 1):S39-S45.
3. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138(11):1198-1206.
4. Zimmermann H, Reichen J. Assessment of the liver function in the surgical patient. In: Blumgart LH, Fong Y, eds. Surgery of the Liver and Biliary Tract. London, England: Saunders; 2000:35-64.
5. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9(4):298-304.
6. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997;84(9):1255-1259.
7. Child CG II, Turcotte JG. Surgery and portal hypertension. In: Child CG III, ed. The Liver and Portal Hypertension. Philadelphia, PA: Saunders; 1964:50-58.
8. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646-649.
9. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864-871.
10. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-470.
11. Freeman RB, Wiesner RH, Harper A, et al. UNOS/OPTN Liver Disease Severity Score: the new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8(9):851-858.
12. Cucchetti A, Ercolani G, Vivarelli M, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006;12(6):966-971.
13. Teh SH, Christein J, Donohue J, et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg. 2005;9(9):1207-1215.
14. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis [published online ahead of print January 25, 2007]. Gastroenterology. 2007;132(4):1261-1269.
15. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234(1):71-78.
16. Capussotti L, Muratore A, Massucco P, Ferrero A, Polastri R, Bouzari H. Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes. Liver Transpl. 2004;10(2)(suppl 1):S64-S68.
17. Capussotti L, Muratore A, Amisano M, Polastri R, Bouzari H, Massucco P. Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival: a European single center experience. Eur J Surg Oncol. 2005;31(9):986-993.
18. Otsuka Y, Duffy JP, Saab S, et al. Postresection hepatic failure: successful treatment with liver transplantation [published online ahead of print January 11, 2007]. Liver Transpl. 2008;13(5):672-679.
19. Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg. 2003;238(6):885-892.
20. Pang YY, Strasberg SM. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2000;2:333-339.
21. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29-36.
22. Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204(5):854-862.
23. Cucchetti A, Ercolani G, Cescon M, et al. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg. 2006;203(5):670-676.
24. Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol. 2003;38(suppl 1):S69-S89.
25. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005;41(1):32-39.
26. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652-1660.
27. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl. 2003;9(1):12-18.
28. Northup PG, Berg CL. Preoperative delta-MELD score does not independently predict mortality after liver transplantation. Am J Transplant. 2004;4(10):1643-1649.
29. Bambha K, Kim WR, Kremers WK, et al. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant. 2004;4(11):1798-1804.
30. Huo TI, Wu JC, Lin HC, et al. Evaluation of the increase in model for end stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol. 2005;42(6):826-832.
31. D'Amico G. Developing concepts on MELD: delta and cutoffs. J Hepatol. 2005;42(6):790-792.